Last updated on February 2018

Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Brief description of study

This is a multicenter, open label study to assess the safety and pharmacokinetics of YKP3089 as adjunctive therapy in subjects with partial onset seizures. Initially, subjects taking phenytoin or phenobarbital will be enrolled followed by additional subjects taking anti-epileptic drugs other than phenytoin and phenobarbital to further investigate long-term safety.

Clinical Study Identifier: NCT02535091

Contact Investigators or Research Sites near you

Start Over

Terence O'Brien

Royal Melbourne Hospital
Parkville, Australia
  Connect »

Wendyl D'Souza

St Vincents Hospital Melbourne
Fitzroy, Australia
  Connect »

Samuel Berkovic

Austin Health
Heidelberg, Australia
  Connect »

Patrick Cerney

Box Hill Hospital
Box Hill, Australia
  Connect »